NASDAQ:TARS | Total Assets | Tarsus Pharmaceuticals, Inc.

Complete source-backed total assets history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Total Assets

DateTotal assetsCurrent assetsCash and equivalentsCurrent securitiesReceivablesInventoryProperty, plant and equipmentOther noncurrent assets
2026-06-30$611.14M$561.99M$204.6M$245.1M$96.03M$4.38M$20.49M$660,000.00
2026-03-31$581.14M$537.23M$102.19M$286.54M$100.34M$4.57M$17.67M$715,000.00
2025-12-31$562.16M$522.78M$183.64M$233.63M$85.06M$4.37M$11.67M$1.86M
2025-09-30$534.56M$501.7M$112.72M$289.11M$72.62M$3.84M$5.75M$1.18M
2025-06-30$494.99M$474.43M$96.65M$284.5M$58.33M$3.87M$3.18M$1.21M
2025-03-31$500.75M$480.77M$175.79M$232.13M$62.43M$2.71M$2.79M$616,000.00
2024-12-31$376.99M$356.71M$94.82M$196.56M$46.76M$2.62M$2.31M$999,000.00
2024-09-30$376.3M$357.12M$176.21M$140.74M$29.16M$2.85M$2.39M$888,000.00
2024-06-30$376.84M$362.59M$181.1M$142.49M$29.53M$2.2M$2.24M$846,000.00
2024-03-31$349.28M$340.72M$193.71M$104.82M$29.89M$4.04M$1.34M$1.32M
2023-12-31$265.49M$256.13M$224.95M$2.5M$16.62M$3.11M$1.47M$1.51M
2023-09-30$268.33M$259.28M$226.67M$20.21M$5.36M$15,000.00$1.61M$1.25M
2023-06-30$188.93M$183.48M$106.77M$71.46M$1.54M$1.45M
2023-03-31$211.21M$208.65M$66M$135.22M$2.5M$1.19M$529,000.00
2022-12-31$227.86M$225.38M$71.66M$145.37M$0.00$0.00$957,000.00$585,000.00
2022-09-30$236.47M$234.08M$169.49M$57.08M$17,000.00$951,000.00$583,000.00
2022-06-30$252.83M$250.28M$245.36M$0.00$17,000.00$963,000.00$600,000.00
2022-03-31$181.48M$178.76M$175.01M$291,000.00$17,000.00$915,000.00$887,000.00
2021-12-31$178.91M$175.95M$171.33M$483,000.00$0.00$755,000.00$1.13M
2021-09-30$190.41M$187.09M$183.8M$519,000.00$1.62M
2021-06-30$203.45M$200.9M$176.74M$20M$481,000.00$1.53M
2021-03-31$193.95M$191.45M$156.18M$25M$589,000.00$1.33M
2020-12-31$171.97M$170.66M$168.13M$0.00$0.00$548,000.00$81,000.00
2020-09-30$92.19M$89.07M$86.33M$604,000.00$1.75M
2020-06-30$53.14M
2020-03-31$55.89M
2019-12-31$58.32M$58.03M$57.95M$154,000.00$6,000.00
2019-09-30$337,000.00
2018-12-31$2.38M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.